EUVIMEDEUVIMED entdecken
Open Access

ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways

Jinrong Zhu, Xiangyu Qiu, Xin Jin, Xiaoya Nie, Shengming Ou, Geyan Wu, Jianfei Shen, Rongxin Zhang

Cellular Oncology · 2024-10 · 47 (5) · 1927-1942

DOI: 10.1007/s13402-024-00976-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 14.08.2024. Verfasst von Jinrong Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guang…. Hauptthemen laut MEDLINE: Lymphangiogenesis, Vascular Endothelial Growth Factor C, Lymphatic Metastasis, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Medical Science and Technology Research Foundation of Guangdong Province, Guangzhou Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangiogenesisVascular Endothelial Growth Factor CLymphatic MetastasisProto-Oncogene Proteins c-aktUp-RegulationEpigenesis, GeneticPhosphatidylinositol 3-KinasesEsophageal Squamous Cell CarcinomaGene Expression Regulation, NeoplasticHumansCell Line, TumorAnimalsMAP Kinase Signaling SystemFemaleMaleEsophageal NeoplasmsMice, NudeMiceMiddle AgedMice, Inbred BALB CPrognosisTranscription FactorsSignal Transduction

Stichwörter der Autor:innen

ESCCHistone modificationsLymphatic metastasisVEGF-CZNF468

Substanzen

Vascular Endothelial Growth Factor CProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTranscription FactorsVEGFC protein, human

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, Guangzhou, China.
  • Biomedicine Research Centre, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provicial Clinical Research Center for Obsterics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical…
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. wugy8@mail2.sysu.edu.cn.
  • Department of Cardiothoracic Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, China. jianfei051@163.com.
  • Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, Guangzhou, China. rxzhang@gdpu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Medical Science and Technology Research Foundation of Guangdong Province
  • Guangzhou Basic and Applied Basic Research Foundation

Zitieren

APA

Zhu, J., Qiu, X., Jin, X., Nie, X., Ou, S., Wu, G., Shen, J., & Zhang, R. (2024). ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways. Cellular Oncology, 47(5), 1927-1942. https://doi.org/10.1007/s13402-024-00976-0

Vancouver

Zhu J, Qiu X, Jin X, Nie X, Ou S, Wu G, et al. ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways. Cellular Oncology. 2024;47(5):1927-1942. doi:10.1007/s13402-024-00976-0

BibTeX
@article{Zhu2024,
  author = {Zhu, Jinrong and Qiu, Xiangyu and Jin, Xin and Nie, Xiaoya and Ou, Shengming and Wu, Geyan and Shen, Jianfei and Zhang, Rongxin},
  title = {ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways},
  journal = {Cellular Oncology},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {1927--1942},
  doi = {10.1007/s13402-024-00976-0}
}
Kostenlos starten →